Acurx Pharmaceuticals/$ACXP

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Acurx Pharmaceuticals

Acurx Pharmaceuticals Inc is a late-stage biopharmaceutical company focused on developing a new class of small-molecule antibiotics for difficult-to-treat bacterial infections. Its approach is to develop antibiotic candidates with a Gram-positive selective spectrum (GPSS) that block the active site of the Gram-positive specific bacterial enzyme deoxyribonucleic acid (DNA) polymerase IIIC (pol IIIC), inhibiting DNA replication and Gram-positive bacterial cell death. Its research and development pipeline includes antibiotic product candidates targeting Gram-positive bacteria, including Clostridioides difficile, methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and drug-resistant Streptococcus pneumoniae and B. anthracis. It operates in a single segment.

Ticker

$ACXP
Sector
Health
Primary listing
NASDAQ

Employees

4
Headquarters
Staten Island, United States
Website
www.acurxpharma.com

ACXP Metrics

BasicAdvanced
$6.6m
-
-$3.89
-
-

ACXP News

AllArticlesVideos
Acurx Pharmaceuticals, Inc. To Present at The Market Movers Investor Summit

Acurx Pharmaceuticals, Inc. To Present at The Market Movers Investor Summit

Newsfile Corp·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs